Granulocyte colony-stimulating factors used in clinical practice : PoloNord registry-based cohort Italian study

Articolo
Data di Pubblicazione:
2014
Citazione:
Granulocyte colony-stimulating factors used in clinical practice : PoloNord registry-based cohort Italian study / D. Fagnani, L. Isa, M.F. Verga, P. Nova, C. Casartelli, V. Filipazzi, M. Danova, G. Farina, P. Pugliese, S. Fava, A. Bertolini, C. Cimminiello, P. Boracchi, G. Marano, C. Panzarino, POLONORD Group. - In: TUMORI. - ISSN 2038-2529. - 100:5(2014), pp. 491-498.
Abstract:
Granulocyte colony-stimulating factors are widely used to reduce myelotoxicity of chemotherapy and to allow its regular administration. National and international guidelines regulate their use. The aim of the study was to evaluate the use of pegfilgrastim and filgrastim/lenograstim in clinical practice, adherence to ASCO and ESMO guidelines, chemotherapy-related complications and adverse reactions.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
cancer; chemotherapy-induced neutropenia; febrile neutropenia; granulocyte colony-stimulating factors
Elenco autori:
D. Fagnani, L. Isa, M.F. Verga, P. Nova, C. Casartelli, V. Filipazzi, M. Danova, G. Farina, P. Pugliese, S. Fava, A. Bertolini, C. Cimminiello, P. Boracchi, G. Marano, C. Panzarino, POLONORD Group
Autori di Ateneo:
BORACCHI PATRIZIA ( autore )
Link alla scheda completa:
https://air.unimi.it/handle/2434/252474

Aree Di Ricerca

Settori (2)